Member access

4-Traders Homepage  >  Shares  >  Nyse  >  MEDNAX Inc    MD   US58502B1061

MEDNAX INC (MD)

7
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales1 8172 1542 4392 7052 9543 271
Operating income (EBITDA)420492559606669738
Operating profit (EBIT)390452513549608688
Pre-Tax Profit (EBT)388448----
Net income241281317334371-
EPS ( $)2,432,783,183,533,92-
Dividend per Share ( $)------
Yield------
Announcement Date01/31/2013
11:00am
01/30/2014
11:00am
01/29/2015
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt116-515657453690
Finance-10,4----
Operating income (EBITDA)420492559606669738
Leverage
(Debt/EBITDA)
0,28x-0,92x1,08x0,68x0,94x
Capital Expenditure14,515,618,121,822,625,0
Book Value Per Share (BVPS)20,3 $23,2 $22,6 $26,9 $30,6 $-
Cash Flow per Share3,28 $4,02 $-4,60 $5,23 $-
Announcement Date01/31/2013
11:00am
01/30/2014
11:00am
01/29/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 6 977 M$ -
Entreprise Value (EV) 7 634 M$ 7 430 M$
Valuation 2015e 2016e
PER (Price / EPS) 20,6x 18,5x
Capitalization / Revenue 2,58x 2,36x
EV / Revenue 2,82x 2,52x
EV / EBITDA 12,6x 11,1x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,71x 2,38x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 20,3% 20,6%
operating Leverage (Delta EBIT / Delta Sales) 0,64x 1,17x
Net Margin (Net Profit / Revenue) 12,4% 12,6%
ROA (Net Profit / Asset) 8,70% 8,70%
ROE (Net Profit / Equities) 13,4% 13,3%
Rate of Dividend - -
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   0,80% 0,76%
Cash Flow / Sales (Taux d'autofinancement) 16,3% 17,0%
Capital Intensity (Assets / Sales) 1,42x 1,44x
Financial Leverage (Net Debt / EBITDA) 1,08x 0,68x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF